Sdiptech AB (publ) (LON:0AAV)
370.00
+181.33 (96.10%)
At close: Nov 4, 2025
Sdiptech AB Revenue
Sdiptech AB had revenue of 1.25B SEK in the quarter ending September 30, 2025, with 3.55% growth. This brings the company's revenue in the last twelve months to 5.21B, up 1.46% year-over-year. In the year 2024, Sdiptech AB had annual revenue of 5.17B with 12.75% growth.
Revenue (ttm)
5.21B SEK
Revenue Growth
+1.46%
P/S Ratio
1.37
Revenue / Employee
2.24M SEK
Employees
2,325
Market Cap
562.27M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.17B | 584.00M | 12.75% |
| Dec 31, 2023 | 4.58B | 1.08B | 30.72% |
| Dec 31, 2022 | 3.51B | 780.80M | 28.66% |
| Dec 31, 2021 | 2.72B | 635.40M | 30.42% |
| Dec 31, 2020 | 2.09B | 263.60M | 14.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |